Could a physio navigator ease cancer treatment side effects?
NCT ID NCT07045740
First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 36 times
Summary
This pilot study tests whether adding a physiotherapist navigator to cancer care helps patients catch and manage side effects early. Twenty-six adults recently diagnosed with cancer will either receive usual care or meet regularly with a physiotherapist navigator for 12-18 weeks. The navigator screens for problems like fatigue and strength loss, then refers patients to other services or provides exercise guidance. The main goal is to see if this approach is feasible and acceptable, not yet to prove it works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
McMaster University
RECRUITINGHamilton, Ontario, L8S 4L8, Canada
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Physiotherapist navigator (a healthcare professional who screens for side effects and coordinates care)
What this could lead to
If successful, this could show that adding a physiotherapist navigator to cancer care teams helps patients manage side effects and improves quality of life.
What could go wrong
This is a very small pilot study (26 people) testing feasibility, not effectiveness. It may not prove whether the navigator actually improves health outcomes.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.